搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
10 天
Diagnosing and treating Non-Hodgkin Lymphoma
Full House” star Dave Coulier revealed he was diagnosed with Non-Hodgkin Lymphoma back in October. It’s a blood cancer that ...
3 天
ASH 2024: inMIND study results position Monjuvi as a promising therapy for R/R follicular ...
The inMIND trial results have elevated expectations for Monjuvi's commercial success, but competition is on the horizon.
3 天
Gerry Turner, 72, says he was diagnosed with an incurable cancer: What is his rare non ...
He further explained he was diagnosed with a slow-growing "bone marrow cancer" called Waldenström's macroglobulinemia (WM): ...
Cure Today
10 天
Expert Explains Lymphoma After Dave Coulier's Diagnosis
An expert from the CURE® advisory board explains the likely treatability of Dave Coulier’s non-Hodgkin lymphoma.
3 天
‘Golden Bachelor’ Star Announces Cancer Diagnosis
Gerry Turner rose to prominence as a septuagenarian star of a reality dating show. In an interview with People, he said he ...
10 天
A CAR T Cell Therapy Offering Hope to Patients with Lymphoma
It was a month before Christmas 2021, and everyone was hoping for a miracle. Jenna had been diagnosed with lymphoma in 2020 ...
Channel NewsAsia Singapore
2 天
Navigating the ups and downs of the lymphoma journey
A haematologist shares insights into the challenges of the disease and the promise of emerging treatment options.
来自MSN
5 小时
39 years after his death, Roger Maris’ legacy lives on in NCFL
It has been 39 years since North Central Florida and New York Yankee legend Roger Maris died. Maris died on December 14, 1985 ...
Targeted Oncology
4 天
Axi-Cel Efficacy in R/R Indolent Non-Hodgkin Lymphoma Sustained at 5 Years
These long-term data support axicabtagene ciloleucel as a highly effective therapeutic approach for patients with relapsed or ...
Taiwan News
6 天
Encouraging Efficacy and Safety: CStone Presents Latest Clinical Data on CS5001 for ...
Preliminary data from the first-in-human study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting demonstrated that CS5001 is well-tolerated and exhibits encouraging ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈